Status:
RECRUITING
RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT
Lead Sponsor:
Peking University People's Hospital
Conditions:
Acute Leukemia
Myelodysplastic Syndromes
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This study aimed to evaluate the efficacy of reduced intensity conditioning (RIC) regimen in elderly or high comorbidity burden patients who receive haploidentical hematopoietic stem cell transplantat...
Detailed Description
RIC regimen was given for elderly patients or those with high comorbidity burden who would receive haplo-HSCT. The elderly patients were defined as older than 55 years. The burden of comorbidities in ...
Eligibility Criteria
Inclusion
- Patients older than 55 years or those with HCT-CI scores of ≥3, without ISD nor URD, receiving haplo-HSCT
Exclusion
- patients having identical sibling or unrelated donors; patients with active infection; patients having organ failure; patients with poor compliance.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03412409
Start Date
February 1 2018
End Date
September 1 2025
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University, Institute of Hematolgoy
Beijing, China